Gottlieb Is Nominee for FDA Commissioner
President Donald Trump announced (here) that he plans to nominate Scott Gottlieb to serve as Food and Drug Administration (FDA) commissioner. Gottlieb is a physician, a resident fellow at the American Enterprise Institute, a venture partner at venture capital firm…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
New Enterprise Associates, and a clinical professor at New York University School of Medicine. Gottlieb was the FDA’s deputy commissioner for medical and scientific affairs from 2005 to 2007. The Senate Health, Education, Labor and Pensions Committee will consider Gottlieb’s nomination. Committee ranking member Patty Murray, D-Wash., in a statement (here) said she will closely evaluate Gottlieb on his approach to food safety, youth tobacco use prevention, and encouraging markets for generic and biosimilar drugs, among other things. Committee Chairman Lamar Alexander, R-Tenn., in a statement (here) lauded Gottlieb’s qualifications as a physician and former FDA official.